Advertisement
The program was designed to update thoracic surgeons and other medicalprofessionals about current diagnostic criteria and treatment optionsavailable for patients with pleural mesothelioma, a rare, asbestos-relatedcancer that attacks the lung's lining. It was co-sponsored by the AmericanAssociation for Thoracic Surgery.
Advertisement
Ms. Clancy spoke with the group of medical professionals about how medicalresearch articles are understood and applied in the courtroom -- sometimes inways not intended by the scientist authors. Her words provoked livelydiscussion among the doctors and research scientists present, includingquestions about the scientific community's responsibility to anticipate thelegal applications of their words.
Baron & Budd has a long-standing relationship with the InternationalMesothelioma Program (IMP). As a member of the IMP's Executive AdvisoryBoard, the law firm is in regular contact with the IMP to remain abreast ofmesothelioma research updates affecting treatment options. Baron & Budd wasinvited to become a member the Executive Board because of our experience andcommitment to working with people with mesothelioma. Baron and Budd was thefirst and remains the longest-standing member of the IMP Executive AdvisoryBoard.
About Baron & Budd, P.C.
Since 1977, the law firm of Baron & Budd, P.C. has championed the rightsof people and communities harmed by corporate misconduct. With 49 attorneysand offices in Texas, California and Louisiana, Baron & Budd enjoys a nationalreputation as a leader of the plaintiffs' bar. The firm represents individualswith mesothelioma and other diseases caused by asbestos; leukemia caused bybenzene; injuries caused by other toxic substances and unsafe pharmaceuticals;water authorities seeking clean-up costs for drinking water contamination;securities investors defrauded by corporate wrongdoing; and consumers in classactions.
Susan Knape, 1-244-521-3605 [email protected]
SOURCE Baron & Budd, P.C.
